Home > Healthcare > Medical Services > Inpatient and Outpatient Services > Extractable and Leachable Testing Services Market

Extractable and Leachable Testing Services Market Trends

Report ID: GMI8466
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Extractable and Leachable Testing Services Market Trends

The growth of the pharmaceutical and biotechnology industry offers significant benefits for extractable and leachable testing services. With a growing emphasis on ensuring product safety, effectiveness, and regulatory compliance, there is an increased demand for these services.

With advancements in novel drug delivery systems, biologics, and combination products, there is a need for specialized testing to assess the compatibility of these complex formulations with packaging materials and ensure product stability.
Further, comprehensive extractable and leachable testing can identify potential risks associated with chemical interactions between drug products and packaging materials, helping companies mitigate these risks early in the development process and avoid costly product recalls or regulatory issues.
Additionally, extractable and leachable testing services contribute to maintaining high-quality standards throughout the product lifecycle, from development and manufacturing to distribution and storage, ensuring that products meet the highest safety and quality requirements.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global extractable and leachable testing services industry was valued at around USD 866.2 million in 2023 and is estimated to reach over USD 2.7 billion by 2032, owing to growing pharmaceutical and biotechnology companies and widespread adoption of single-use technology.

Container closure systems segment of extractable and leachable testing services industry is estimated to account for USD 868.5 million by 2032, as they ensure product integrity during storage and transport, minimizing the likelihood of extractables and leachable contaminating the product, thereby preserving its quality.

North America extractable and leachable testing services market accounted for USD 351 million in 2023 and is predicted to witness substantial growth through 2032, driven by advanced technological infrastructure, including state-of-the-art laboratories in the region.

BA Sciences, Eurofins Scientific, Intertek Group plc, Limerston Capital LLP, Merck & Co., Inc., Pacific Biolabs, Inc, SGS Societe Generale de Surveillance SA, Sotera Health Co, West Pharmaceutical Services, Inc, Wickham Micro Limited, WuXi AppTec Co., Ltd. are some of the major industry contenders.